Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C Meeting Abstract
| Authors: | Garassino. M. C.; Thomas, M.; Felip. E.; Sakai. H.; Le, X.; Veillon, R.; Smith. E. F.; Mazieres, J.; Cortot, A. B.; Raskin, J.; Viteri, S.; Yang, J. C. H.; Ahn, M. J.; Wu, Y. L.; Ma, R.; Zhao, J.; O'Brate, A.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. |
| Abstract Title: | Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C |
| Meeting Title: | 2023 European Lung Cancer Congress |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2023 Mar 29-Apr 1 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-04-01 |
| Start Page: | e7 |
| End Page: | e8 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.09.021 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: PPD02.03 |
